AKT1 and cancer: Together, a number of recent studies have provided the molecular basis for the observation that small-molecule inhibitors of PI3K/Akt/mTOR signaling represent a potent strategy to enhance the sensitivity of cancer cells toward cell death induction via the mitochondrial pathway of apoptosis.